AUDITORS’ ORATORY: How to cope with increasing transfers between notified bodies
This article was originally published in Clinica
Executive Summary
In this latest instalment of Auditors’ Oratory, Gert Bos, president of TEAM-NB and head of regulatory and clinical affairs at BSI, explains why the number of notified bodies active in the medical devices field continues to drop and cause uncertainty for industry, what the practical impact is on manufacturers and notified bodies, and how TEAM-NB are introducing solutions to help smooth out the problems that occur in these situations